NCT04930991 2026-01-08
OU202005AJ
University of Oklahoma
Phase EARLY_PHASE1 Recruiting
Clinical Trials
7 trialsNCT05680870 2025-09-09
The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients
Tanta University
Phase 3 Completed
NCT07016737 2025-06-12
ESO-Nanjing12
Jiangsu Cancer Institute & Hospital
Phase 3 Enrolling by invitation
NCT04154748 2019-11-19
Argon Plasma Coagulation for Barrett's Esophagus
Maria Sklodowska-Curie National Research Institute of Oncology
Phase NA Completed
NCT01566474 2019-09-13
Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study
Aragon Institute of Health Sciences
Phase 3 Completed
NCT01093755 2016-03-17
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
Mayo Clinic
Phase 4 Completed
NCT01465113 2016-03-10
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed